Antifungal activity of colistin against Mucorales species in vitro and in a murine model of Rhizopus oryzae pulmonary infection

Antimicrobial Agents and Chemotherapy

Volumn 54, Issue 1, 2010, Pages 484-490

  Ben Ami, Ronen ^a   Lewis, Russell E ^b   Tarrand, Jeffrey ^a   Leventakos, Konstantinos ^a   Kontoyiannis, Dimitrios P ^a,b  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNIVERSITY OF HOUSTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; COLISTIMETHATE; COLISTIN; PLACEBO;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIFUNGAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; ELECTRON MICROSCOPY; FEMALE; FUNGICIDAL ACTIVITY; IMMUNE DEFICIENCY; IN VIVO STUDY; LUNG INFECTION; MINIMUM INHIBITORY CONCENTRATION; MOUSE; MUCORMYCOSIS; NONHUMAN; PRIORITY JOURNAL; RHIZOPUS ORYZAE; SACCHAROMYCES CEREVISIAE; STAINING; TONOPLAST;

ADENOSINE TRIPHOSPHATE; ANIMALS; ANTIFUNGAL AGENTS; COLISTIN; CYTOPLASM; FEMALE; HYPHAE; LUNG; LUNG DISEASES, FUNGAL; MICE; MICE, INBRED BALB C; MICROBIAL SENSITIVITY TESTS; MICROSCOPY, ELECTRON, TRANSMISSION; MUCORALES; MUCORMYCOSIS; RHIZOPUS; SPORES, FUNGAL; TETRAZOLIUM SALTS; VACUOLES;

EID: 73849142302     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00956-09     Document Type: Article

References (25)

1. Aoki, N., K. Tateda, Y. Kikuchi, S. Kimura, C. Miyazaki, Y. Ishii, Y. Tanabe, F. Gejyo, and K. Yamaguchi. 2009. Efficacy of colistin combination therapy in a mouse model of pneumonia caused by multidrug-resistant Pseudomonas aeruginosa. J. Antimicrob. Chemother. 63:534-542.
2. Bowman, J. C., P. S. Hicks, M. B. Kurtz, H. Rosen, D. M. Schmatz, P. A. Liberator, and C. M. Douglas. 2002. The antifungal echinocandin caspofungin acetate kills growing cells of Aspergillus fumigatus in vitro. Antimicrob. Agents Chemother. 46:3001-3012.
3. Chamilos, G., R. E. Lewis, and D. P. Kontoyiannis. 2006. Lovastatin has significant activity against zygomycetes and interacts synergistically with voriconazole. Antimicrob. Agents Chemother. 50:96-103.
4. Clinical and Laboratory Standards Institute. 2008. Reference method for broth dilution antifungal susceptibility testing of filamentous fungi. Approved standard, 2nd ed. Clinical and Laboratory Standards Institute, Wayne, PA.
5. Espinel-Ingroff, A., A. Fothergill, J. Peter, M. G. Rinaldi, and T. J. Walsh. 2002. Testing conditions for determination of minimum fungicidal concentrations of new and established antifungal agents for Aspergillus spp.: NCCLS collaborative study. J. Clin. Microbiol. 40:3204-3208.
6. Falagas, M. E., S. K. Kasiakou, S. Tsiodras, and A. Michalopoulos. 2006. The use of intravenous and aerosolized polymyxins for the treatment of infections in critically ill patients: a review of the recent literature. Clin. Med. Res. 4:138-146.
7. Galani, I., F. Kontopidou, M. Souli, P. D. Rekatsina, E. Koratzanis, J. Deliolanis, and H. Giamarellou. 2008. Colistin susceptibility testing by Etest and disk diffusion methods. Int. J. Antimicrob. Agents 31:434-439.
8. Goodwin, N. J., and E. A. Friedman. 1968. The effects of renal impairment, peritoneal dialysis, and hemodialysis on serum sodium colistimethate levels. Ann. Intern. Med. 68:984-994.
9. Grove, S. N., and C. E. Bracker. 1970. Protoplasmic organization of hyphal tips among fungi: vesicles and Spitzenkorper. J. Bacteriol. 104:989-1009.
10. Hancock, R. E., and D. S. Chapple. 1999. Peptide antibiotics. Antimicrob. Agents Chemother. 43:1317-1323.
11. Higgins, D. L., R. Chang, D. V. Debabov, J. Leung, T. Wu, K. M. Krause, E. Sandvik, J. M. Hubbard, K. Kaniga, D. E. Schmidt, Jr., Q. Gao, R. T. Cass, D. E. Karr, B. M. Benton, and P. P. Humphrey. 2005. Telavancin, a multifunctional lipoglycopeptide, disrupts both cell wall synthesis and cell membrane integrity in methicillin-resistant Staphylococcus aureus. Antimicrob. Agents Chemother. 49:1127-1134.
12. Kontoyiannis, D. P., and R. E. Lewis. 2006. Invasive zygomycosis: update on pathogenesis, clinical manifestations, and management. Infect. Dis. Clin. North Am. 20:581-607.
13. Kontoyiannis, D. P., M. S. Lionakis, R. E. Lewis, G. Chamilos, M. Healy, C. Perego, A. Safdar, H. Kantarjian, R. Champlin, T. J. Walsh, and I. I. Raad. 2005. Zygomycosis in a tertiary-care cancer center in the era of Aspergillus-active antifungal therapy: a case-control observational study of 27 recent cases. J. Infect. Dis. 191:1350-1360.
14. Kroeger, L. A., L. B. Hovde, I. F. Mitropoulos, J. Schafer, and J. C. Rotschafer. 2007. Colistin methanesulfonate against multidrug-resistant Acinetobacter baumannii in an in vitro pharmacodynamic model. Antimicrob. Agents Chemother. 51:3431-3433.
15. Lamaris, G. A., R. Ben-Ami, R. E. Lewis, G. Chamilos, G. Samonis, and D. P. Kontoyiannis. 2009. Increased virulence of zygomycetes organisms following exposure to voriconazole: a study involving fly and murine models of zygomycosis. J. Infect. Dis. 199:1399-1406.
16. Landman, D., C. Georgescu, D. A. Martin, and J. Quale. 2008. Polymyxins revisited. Clin. Microbiol. Rev. 21:449-465.
17. Leventakos, K., R. E. Lewis, and D. P. Kontoyiannis. 2009. Effect of low and high dose of caspofungin (CAS) in a neutropenic and a steroid treated murine model of pulmonary mucormycosis (MCM). Abstr. 49th Intersci. Conf. Antimicrob. Agents Chemother., abstr. M-1690.
18. Lewis, R. E., D. J. Diekema, S. A. Messer, M. A. Pfaller, and M. E. Klepser. 2002. Comparison of Etest, chequerboard dilution and time-kill studies for the detection of synergy or antagonism between antifungal agents tested against Candida species. J. Antimicrob. Chemother. 49:345-351.
19. Li, J., C. R. Rayner, R. L. Nation, R. J. Owen, D. Spelman, K. E. Tan, and L. Liolios. 2006. Heteroresistance to colistin in multidrug-resistant Acinetobacter baumannii. Antimicrob. Agents Chemother. 50:2946-2950.
20. Mackay, D. N., and D. Kaye. 1964. Serum concentrations of colistin in patients with normal and impaired renal function. N. Engl. J. Med. 270:394-397.
21. Pyrgos, V., S. Shoham, and T. J. Walsh. 2008. Pulmonary zygomycosis. Semin. Respir. Crit. Care Med. 29:111-120.
22. Reed, M. D., R. C. Stern, M. A. O'Riordan, and J. L. Blumer. 2001. The pharmacokinetics of colistin in patients with cystic fibrosis. J. Clin. Pharmacol. 41:645-654.
23. Schwartz, S. N., G. Medoff, G. S. Kobayashi, C. N. Kwan, and D. Schlessinger. 1972. Antifungal properties of polymyxin B and its potentiation of tetracycline as an antifungal agent. Antimicrob. Agents Chemother. 2:36-40.
24. Simitsopoulou, M., E. Roilides, A. Maloukou, C. Gil-Lamaignere, and T. J. Walsh. 2008. Interaction of amphotericin B lipid formulations and triazoles with human polymorphonuclear leucocytes for antifungal activity against Zygomycetes. Mycoses 51:147-154.
25. Vida, T. A., and S. D. Emr. 1995. A new vital stain for visualizing vacuolar membrane dynamics and endocytosis in yeast. J. Cell Biol. 128:779-792.